Sinopharm Group Co (HK:1099) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sinopharm Group Co. Ltd has released its principal unaudited financial data for the first half of 2024, revealing a modest increase in total assets by 3.39%, revenue by 2.55%, and net profit attributable to shareholders by 1.62% compared to the previous year. Despite the growth, the company experienced a decrease in net cash flow from operating activities and a slight dip in the weighted average return on net assets. The financial indicators suggest steady performance amidst challenging market conditions.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.
